The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses

EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

(2010) W. G. Dixon et al.   ANNALS OF THE RHEUMATIC DISEASES

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Herpes Zoster Risk Factors in a National Cohort of Veterans with Rheumatoid Arthritis

(2009) Jay R. McDonald et al.   CLINICAL INFECTIOUS DISEASES

Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents

(2009) Anja Strangfeld   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Initiation of rheumatoid arthritis treatments and the risk of serious infections

(2009) Carlos G. Grijalva et al.   RHEUMATOLOGY

Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis

(2008) J N Hoes et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial

(2008) T Pincus et al.   ANNALS OF THE RHEUMATIC DISEASES

Dose-related patterns of glucocorticoid-induced side effects

(2008) D Huscher et al.   ANNALS OF THE RHEUMATIC DISEASES

Use of glucocorticoids and risk of infections

(2008) Maurizio Cutolo et al.   AUTOIMMUNITY REVIEWS

Serious infections during anti-TNFα treatment in rheumatoid arthritis patients

(2008) Ennio Giulio Favalli et al.   AUTOIMMUNITY REVIEWS

AHRQ Series Paper 4: Assessing harms when comparing medical interventions: AHRQ and the Effective Health-Care Program

(2008) Roger Chou et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY